What is the dosage of Brukinsa?

Brukinsa is available in 1 dosages, including 80 mg Cap

What does Brukinsa treat?

Brukinsa treats Mantle-Cell Lymphoma

What is Brukinsa made of?

Brukinsa contains zanubrutinib which is a undefined

How is Brukinsa administered?

Brukinsa is administered as a Oral Pill

What is Brukinsa mechanism of action?

Brukinsa mechanism of action is

Dosage & Administration Drug label Samples Prior authorization Financial assistance

Patient education

Brukinsa

(zanubrutinib)

zanubrutinib 80 MG Oral Capsule [Brukinsa]

NO BLACK BOX WARNING

Dosage & administration

* Recommended dosage: 160 mg orally twice daily or 320 mg orally once daily; swallow whole with water and with or without food.
* Reduce BRUKINSA dose in patients with severe hepatic impairment.
* Advise patients not to open, break, or chew capsules.
* Manage toxicity using treatment interruption, dose reduction, or discontinuation.

drug label

Brukinsa prescribing information

Have more Brukinsa questions?

Submit MSL Request

Learn More

Need to report a Brukinsa issue?

ONLINE FORMReport adverse event

Learn More

samples

Request Brukinsa samples

NOT PROVIDED BY BRANDSample Request

Learn More

prior authorization

Brukinsa Prior authorization resources

Complete Letter of Medical Necessity

NOT PROVIDED BY BRANDCoverage Authorization Request

Coverage Authorization Appeals

Learn More

Benefits investigation

Brukinsa Enrollment Form

Learn More

Reimbursement help (FRM)

Receive Assistance from an FRM Regarding Reimbursement Information

Learn More

financial assistance

Brukinsa Financial assistance options

Co-pay savings program

commercial only

Brukinsa Enrollment Form

Enroll in Patient Savings Program

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Bridge program

commercial only

Brukinsa Enrollment Form

Enroll in Bridge Program

Learn More

Overview

Provide patient immediate access to therapy during an insurance delay (typically new starts; some may cover change in insurance)
Limited time/ fill (typically 7-30 days; some may offer additional fill for continued delay up to certain limit)

Patient benefit

100% free (outside of insurance)

Patient eligibility

HCP must enroll patient
May be limited to commercially insured patients (i.e., no government beneficiaries); some programs may allow government beneficiaries

How to sign up

Typically HCP assisted enrollment (via form)

Foundation programs

under insured

no insurance

goverment insurance

65+

Brukinsa Enrollment Form

Patient Assistance Program

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.

How to sign up

Patients submit proof of out-of-pocket drug costs to charities for reimbursement

patient education

Brukinsa Patient education

Getting started on Brukinsa

NOT PROVIDED BY BRANDInstructions For Use: Waldenström’s Macroglobulinemia (WM)

NOT PROVIDED BY BRANDInstructions For Use: Mantle Cell Lymphoma (MCL)

NOT PROVIDED BY BRANDInstructions For Use: Relapsed or Refractory Marginal Zone Lymphoma (MZL)